Published May 21, 2026 | Version v1

Figure 1 from: Ivanov H, Stoyanova V, Linev A, Pochileev I, Chirlova-Kulenska A, Chapkanov A, Dimov R (2026) Postoperative circulating cell-free DNA (cfDNA) dynamics as an early indicator of molecular residual disease in lung cancer: preliminary results and correlation with TNM status, adjuvant therapy, and clinical outcome. Pharmacia 73: e187008. https://doi.org/10.3897/pharmacia.73.e187008

  • 1. Department of Medical Genetics, Medical University of Plovdiv, Plovdiv, Bulgaria
  • 2. Department of Special Surgery, Medical University of Plovdiv, Plovdiv, Bulgaria

Description

Figure 1 Longitudinal cfDNA concentrations measured at four time points (T0–T3) for all patients. The main plot shows the full range of cfDNA values starting from 0 ng/μL. The inset provides a zoomed view of the 0.2–0.4 ng/μL range to improve visualization of interindividual differences. Solid lines represent surviving patients, while dashed lines represent deceased patients.

Files

Files (223.2 kB)

Name Size Download all
md5:21354c4135284e6e9e7d2a113ffd96c3
223.2 kB Download

Additional details

Related works

Is part of
Journal article: 10.3897/pharmacia.73.e187008 (DOI)
Journal article: https://zenodo.org/record/20352623 (URL)